Found 5 matching trials
Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
PHASE1The purpose of this research study is to evaluate Immunotherapy with a pept...
Status
Active Not Recruiting
Location
Lee Moffitt Cancer Center and Research Institute
Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma
PHASE1The purpose of this study is to determine the safety and tolerability of PV...
Location
Winship Cancer Institute, Emory University
A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
PHASE1This research study is studying a targeted therapy as a possible treatment ...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer
PHASE2Evaluating the combination of the investigational, multi-peptide cancer vac...
Location
Multiple Locations
PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
PHASE1This research study is studying immunotherapy as a possible treatment for m...
Status
Active Not Recruiting
Location
Massachusetts General Hospital